Targeting the latent human cytomegalovirus reservoir with virus specific nanobodies
T. W. M. De Groof, E. G. Elder, R. Heukers, E. Y. Lim, M. Wills, J. H. Sinclair, M. J. Smit
This study develops a nanobody that partially inhibits HCMV receptor signaling and enhances T-cell killing of latently infected monocytes, offering a potential therapy for clearing HCMV reservoirs in transplant patients.
Nature Communications · Jul 21, 2021Peer-reviewedMicrobiology